These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 9028332)
1. Stat1 is induced and activated by all-trans retinoic acid in acute promyelocytic leukemia cells. Gianni M; Terao M; Fortino I; LiCalzi M; Viggiano V; Barbui T; Rambaldi A; Garattini E Blood; 1997 Feb; 89(3):1001-12. PubMed ID: 9028332 [TBL] [Abstract][Full Text] [Related]
2. Retinoic acid induces signal transducer and activator of transcription (STAT) 1, STAT2, and p48 expression in myeloid leukemia cells and enhances their responsiveness to interferons. Matikainen S; Ronni T; Lehtonen A; Sareneva T; Melén K; Nordling S; Levy DE; Julkunen I Cell Growth Differ; 1997 Jun; 8(6):687-98. PubMed ID: 9186002 [TBL] [Abstract][Full Text] [Related]
3. Retinoic acid resistance in NB4 APL cells is associated with lack of interferon alpha synthesis Stat1 and p48 induction. Pelicano L; Brumpt C; Pitha PM; Chelbi-Alix MK Oncogene; 1999 Jul; 18(27):3944-53. PubMed ID: 10435617 [TBL] [Abstract][Full Text] [Related]
4. Differential gene expression in retinoic acid-induced differentiation of acute promyelocytic leukemia cells, NB4 and HL-60 cells. Lee KH; Chang MY; Ahn JI; Yu DH; Jung SS; Choi JH; Noh YH; Lee YS; Ahn MJ Biochem Biophys Res Commun; 2002 Sep; 296(5):1125-33. PubMed ID: 12207890 [TBL] [Abstract][Full Text] [Related]
5. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization. Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843 [TBL] [Abstract][Full Text] [Related]
6. Interferon augments PML and PML/RAR alpha expression in normal myeloid and acute promyelocytic cells and cooperates with all-trans retinoic acid to induce maturation of a retinoid-resistant promyelocytic cell line. Nason-Burchenal K; Gandini D; Botto M; Allopenna J; Seale JR; Cross NC; Goldman JM; Dmitrovsky E; Pandolfi PP Blood; 1996 Nov; 88(10):3926-36. PubMed ID: 8916959 [TBL] [Abstract][Full Text] [Related]
7. AM580, a stable benzoic derivative of retinoic acid, has powerful and selective cyto-differentiating effects on acute promyelocytic leukemia cells. Gianní M; Li Calzi M; Terao M; Guiso G; Caccia S; Barbui T; Rambaldi A; Garattini E Blood; 1996 Feb; 87(4):1520-31. PubMed ID: 8608243 [TBL] [Abstract][Full Text] [Related]
8. [Role of auto-secreted interferon α in all-trans retinoic acid-induced expression of RIG-G gene]. Lou YJ; Pan XR; Xu GP; Zhuang LK; Jia PM; Tong JH Zhonghua Yi Xue Za Zhi; 2012 Jan; 92(2):124-7. PubMed ID: 22490698 [TBL] [Abstract][Full Text] [Related]
9. Interferons induce normal and aberrant retinoic-acid receptors type alpha in acute promyelocytic leukemia cells: potentiation of the induction of retinoid-dependent differentiation markers. Gianní M; Zanotta S; Terao M; Rambaldi A; Garattini E Int J Cancer; 1996 Sep; 68(1):75-83. PubMed ID: 8895544 [TBL] [Abstract][Full Text] [Related]
10. The aberrant fusion proteins PML-RAR alpha and PLZF-RAR alpha contribute to the overexpression of cyclin A1 in acute promyelocytic leukemia. Müller C; Yang R; Park DJ; Serve H; Berdel WE; Koeffler HP Blood; 2000 Dec; 96(12):3894-9. PubMed ID: 11090075 [TBL] [Abstract][Full Text] [Related]
11. Retinoic acid activates interferon regulatory factor-1 gene expression in myeloid cells. Matikainen S; Ronni T; Hurme M; Pine R; Julkunen I Blood; 1996 Jul; 88(1):114-23. PubMed ID: 8704165 [TBL] [Abstract][Full Text] [Related]
12. Tyrosine kinase inhibitor STI571 potentiates the pharmacologic activity of retinoic acid in acute promyelocytic leukemia cells: effects on the degradation of RARalpha and PML-RARalpha. Gianni' M; Kalaç Y; Ponzanelli I; Rambaldi A; Terao M; Garattini E Blood; 2001 May; 97(10):3234-43. PubMed ID: 11342454 [TBL] [Abstract][Full Text] [Related]
13. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia. Guidez F; Ivins S; Zhu J; Söderström M; Waxman S; Zelent A Blood; 1998 Apr; 91(8):2634-42. PubMed ID: 9531570 [TBL] [Abstract][Full Text] [Related]
14. Growth inhibition of human acute promyelocytic leukemia NB-4 cells by interferons and all-trans retinoic acid: trans-modulation of inducible gene expression pathways. Kumar R; Korutla L Anticancer Res; 1995; 15(2):353-60. PubMed ID: 7763006 [TBL] [Abstract][Full Text] [Related]
15. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML. Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078 [TBL] [Abstract][Full Text] [Related]
16. Expression of the Zn finger gene, EVI-1, in acute promyelocytic leukemia. Xi ZF; Russell M; Woodward S; Thompson F; Wagner L; Taetle R Leukemia; 1997 Feb; 11(2):212-20. PubMed ID: 9009083 [TBL] [Abstract][Full Text] [Related]
17. Retinoic acid and granulocyte colony-stimulating factor synergistically induce leukocyte alkaline phosphatase in acute promyelocytic leukemia cells. Gianní M; Terao M; Zanotta S; Barbui T; Rambaldi A; Garattini E Blood; 1994 Apr; 83(7):1909-21. PubMed ID: 7511442 [TBL] [Abstract][Full Text] [Related]